Literature DB >> 409345

In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.

C C Sanders, W E Sanders.   

Abstract

Rosamicin was significantly more active against Haemophilus and Neisseria than are many antibiotics currently used to treat or prevent infection caused by these organisms. This enhanced activity was also observed against penicillinase-producing strains.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 409345      PMCID: PMC429902          DOI: 10.1128/AAC.12.2.293

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors:  J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

3.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

4.  Hemophilus influenzae type B susceptibility to 17 antibiotics.

Authors:  B B Emerson; A L Smith; A L Harding; D H Smith
Journal:  J Pediatr       Date:  1975-04       Impact factor: 4.406

5.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

  5 in total
  10 in total

1.  In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.

Authors:  J W Biddle; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

Review 2.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.

Authors:  J R DiPersio; T L Krafczyk
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

4.  In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.

Authors:  T F Smith; H E Washton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.

Authors:  J A Robertson; J E Coppola; O R Heisler
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  Comparative activity of six beta-lactam antibiotics against strains of Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae.

Authors:  L A Soares; C E Melles
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.

Authors:  M G Bergeron; P Simard; P Provencher
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

8.  Rosaramicin versus penicillin G in experimental Pneumococcal meningitis.

Authors:  C M Nolan; T P Monson; W C Ulmer
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.

Authors:  T F Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

10.  In vitro activity of rosaramicin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.